4.6 Article

Therapeutic ROS and Immunity in Cancer-The TRIC-21 Meeting

期刊

CANCERS
卷 13, 期 18, 页码 -

出版社

MDPI
DOI: 10.3390/cancers13184549

关键词

cold physical plasma; combination therapy; medical gas plasma technology; oncology; reactive oxygen species; RNS; tumor immunology

类别

资金

  1. National Science Foundation [1747760]
  2. Div Of Industrial Innovation & Partnersh
  3. Directorate For Engineering [1747760] Funding Source: National Science Foundation

向作者/读者索取更多资源

The first Therapeutic ROS and Immunity in Cancer (TRIC) meeting was organized by the ZIK plasmatis research center and ONKOTHER-H research program in Germany, bringing together 66 scientists from 12 countries and 5 continents to discuss cutting-edge research on therapeutic ROS and immunology in cancer treatment, with a focus on gas plasma technology. The conference aimed to facilitate interdisciplinary discussions and explore innovative applications of gas plasma technology in cancer therapy.
The first Therapeutic ROS and Immunity in Cancer (TRIC) meeting was organized by the excellence research center ZIK plasmatis (with its previous Frontiers in Redox Biochemistry and Medicine (FiRBaM) and Young Professionals' Workshop in Plasma Medicine (YPWPM) workshop series in Northern Germany) and the excellence research program ONKOTHER-H (Rostock/Greifswald, Germany). The meeting showcased cutting-edge research and liberated discussions on the application of therapeutic ROS and immunology in cancer treatment, primarily focusing on gas plasma technology. The 2-day hybrid meeting took place in Greifswald and online from 15-16 July 2021, facilitating a wide range of participants totaling 66 scientists from 12 countries and 5 continents. The meeting aimed at bringing together researchers from a variety of disciplines, including chemists, biochemists, biologists, engineers, immunologists, physicists, and physicians for interdisciplinary discussions on using therapeutic ROS and medical gas plasma technology in cancer therapy with the four main sessions: Plasma, Cancer, Immunity, Plasma combination therapies, Plasma risk assessment and patients studies, and Plasma mechanisms and treated liquids in cancer. This conference report outlines the abstracts of attending scientists submitted to this meeting.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据